Treat ambient scribes as distinct products with measurable differences, not as one uniform category.
AI value · Time writing each note
Verified
Nabla arm fell from 4:30 to 3:49; a 9.5% greater reduction than control.
DAX did not significantly improve time versus control.
Before
Conducts the visit and writes the note in the EHR. → Completes and reviews documentation.
After
Records the conversation and generates a draft note. → Reviews, corrects, and signs the draft.
Human boundary
Physicians decide whether any generated content enters the record.
Why it matters
Ambient tools can draft notes in practice, but vendor-specific efficiency and error results require comparison.
How the work changed
Before
How the work ran before the change.
Step 1 of 2
Outpatient physician
Conducts the visit and writes the note in the EHR.
ControlPhysician signature.
Step 2 of 2
Physician
Completes and reviews documentation.
ControlClinical accountability.
What changed
Ambient tools can draft notes in practice, but vendor-specific efficiency and error results require comparison.
Decision rightHuman moves from creator to judge
After
How the same work runs now.
Step 1 of 2
Ambient AI scribe
Records the conversation and generates a draft note.
ControlTwo-month randomized clinical deployment.
Step 2 of 2
Physician
Reviews, corrects, and signs the draft.
ControlPhysician vigilance for clinically significant inaccuracies.
Process model built from the published workflow evidence for UCLA Health. Every step, actor, and control appears in full below.Every step, actor, and control
Exception path
Inaccurate output is corrected or discarded and documented manually; adverse events follow clinical safety reporting.
Decision authority
Physicians decide whether any generated content enters the record.
Before
#
Actor
Action
Control
01
Outpatient physician
Conducts the visit and writes the note in the EHR.
Physician signature.
02
Physician
Completes and reviews documentation.
Clinical accountability.
After
#
Actor
Action
Control
01
Ambient AI scribe
Records the conversation and generates a draft note.
Two-month randomized clinical deployment.
02
Physician
Reviews, corrects, and signs the draft.
Physician vigilance for clinically significant inaccuracies.
Work that left the path
Some initial note composition
Human role before
Physicians composed notes directly.
Human role after
Physicians edit and validate drafts while retaining complete clinical and signature responsibility.
AI role
Decision mode: draft documentation only; no diagnosis, order, or signature authority.
Outcomes
Time writing each note
Verified
Control arm fell from 4:22 to 4:04 per note.→Nabla arm fell from 4:30 to 3:49; a 9.5% greater reduction than control.
November 4, 2024-January 3, 2025. · 238 physicians, 14 specialties, about 72,000 encounters.
DAX did not significantly improve time versus control.
Safety and accuracy
Verified
Usual physician-authored documentation.→One mild adverse event; clinically significant inaccuracies were reported occasionally for both products.
Two-month randomized trial. · Two scribe products across 238 physicians.
Requires continuing physician vigilance; product performance was not uniform.
What leaders can reuse
Anti-pattern
Scaling a category-wide claim when one tested product did not beat control.
Questions
01Which product-specific metric matters?
02How are inaccuracies sampled?
03Do savings persist at scale?
Portability conditions
Physician review
Safety reporting
EHR telemetry
Product-specific evaluation
Reputation risk
medium
Evidence and authority
What the public record supports.
Current · updated
1 peer reviewed; publication outcomes are verified.
Bundle 1.0.0 · reviewed 2026-09-06 · stable ID 868ad97f92d5e208